期刊文献+

Percutaneous biliary stent combined with brachytherapy using 125I seeds for treatment of unresectable malignant obstructive jaundice:A meta-analysis 被引量:2

下载PDF
导出
摘要 BACKGROUND Malignant obstructive jaundice(MOJ)is a common pathologic manifestation of malignant biliary obstruction.Recently,several clinical trials have explored the clinical effectiveness of intraluminal^(125)I seed-based brachytherapy for MOJ patients,and various outcomes have been reported.AIM To assess the efficacy and safety of percutaneous biliary stents with^(125)I seeds compared to conventional metal stents in patients with unresectable MOJ.METHODS A systematic search of English-language databases(PubMed,Embase,Cochrane Library,and Web of Science)was performed to identify studies published prior to June 2020 that compared stents with or without^(125)I seeds in the treatment of unresectable MOJ.The outcomes analyzed included primary outcomes(stent patency and overall survival)and secondary outcomes(complications and liver function parameters).RESULTS Six randomized controlled trials and four retrospective studies involving 875 patients were eligible for the analysis.Of the 875 included patients,404 were treated with^(125)I seed stents,while 471 were treated with conventional stents.Unadjusted pooled analysis demonstrated that compared to conventional stents,^(125)I seed stents extended the stent patency time[hazard ratio(HR)=0.36,95%confidence interval(CI)=0.28-0.45,P<0.0001]and overall survival period(HR=0.52,95%CI=0.42–0.64,P<0.00001).Subgroup analyses based on the type of^(125)I seed stent and type of study design showed consistent results.However,there were no significant differences in the occurrence of total complications[odds ratio(OR)=1.12,95%CI=0.75-1.67,P=0.57],hemobilia(OR=1.02,95%CI=0.45-2.3,P=0.96),pancreatitis(OR=1.79,95%CI=0.42-7.53,P=0.43),cholangitis(OR=1.13,95%CI=0.60-2.13,P=0.71),or pain(OR=0.67,95%CI=0.22-2,P=0.47).In addition,there were no reductions in the levels of serum indices,including total bilirubin[mean difference(MD)=10.96,95%CI=-3.56-25.49,P=0.14],direct bilirubin(MD=7.37,95%CI=-9.76-24.5,P=0.4),alanine aminotransferase(MD=7.52,95%CI=-0.71-15.74,P=0.07),and aspartate aminotransferase(MD=-4.77,95%CI=-19.98-10.44,P=0.54),after treatment.Publication bias was detected regarding the outcome overall survival;however,the conclusions were not changed after the adjustment.CONCLUSION Placement of stents combined with brachytherapy using^(125)I seeds contributes to a longer stent patency and higher overall survival than placement of conventional stents without extra complications or severe liver damage.Thus,it can be considered an effective and safe treatment for unresectable MOJ.
出处 《World Journal of Clinical Cases》 SCIE 2021年第35期10979-10993,共15页 世界临床病例杂志
基金 the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission,No.2020KY1086 and No.2020KY1087.
  • 相关文献

参考文献1

二级参考文献53

  • 1Y.NIMURA.Preoperative biliary drainage before resection for cholangiocarcinoma (Pro)[J]. HPB . 2009 (2)
  • 2Jaap J. Kloek,Niels A. Gaag,Yalda Aziz,Erik A. J. Rauws,Otto M. Delden,Johan S. Lameris,Olivier R. C. Busch,Dirk J. Gouma,Thomas M. Gulik.Endoscopic and Percutaneous Preoperative Biliary Drainage in Patients with Suspected Hilar Cholangiocarcinoma[J]. Journal of Gastrointestinal Surgery . 2010 (1)
  • 3Paola Figueroa-Barojas,Mihir R. Bakhru,Nagy A. Habib,Kristi Ellen,Jennifer Millman,Armeen Jamal-Kabani,Monica Gaidhane,Michel Kahaleh,Jose G. de la Mora-Levy.Safety and Efficacy of Radiofrequency Ablation in the Management of Unresectable Bile Duct and Pancreatic Cancer: A Novel Palliation Technique[J].Journal of Oncology.2013
  • 4Werner Hartwig,Thilo Hackert,Ulf Hinz,Alexander Gluth,Frank Bergmann,Oliver Strobel,Markus W. Büchler,Jens Werner.Pancreatic Cancer Surgery in the New Millennium: Better Prediction of Outcome[J].Annals of Surgery.2011(2)
  • 5Janak N. Shah,Fernando Marson,Frank Weilert,Yasser M. Bhat,Thai Nguyen-Tang,Richard E. Shaw,Kenneth F. Binmoeller.Single-operator, single-session EUS-guided anterograde cholangiopancreatography in failed ERCP or inaccessible papilla[J].Gastrointestinal Endoscopy.2012(1)
  • 6Jeffrey H. Lee,Somashekar G. Krishna,Amanpal Singh,Harshad S. Ladha,Rebecca S. Slack,Srinivas Ramireddy,Gottumukkala S. Raju,Marta Davila,William A. Ross.Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients[J].Gastrointestinal Endoscopy.2013(2)
  • 7Sung Ill Jang,Jie-Hyun Kim,Jung Whan You,Kwangwon Rhee,Se Joon Lee,Ho Gak Kim,Jimin Han,Im Hee Shin,Sang-Heum Park,Dong Ki Lee.Efficacy of a Metallic Stent Covered with a Paclitaxel-Incorporated Membrane Versus a Covered Metal Stent for Malignant Biliary Obstruction: A Prospective Comparative Study[J].Digestive Diseases and Sciences.2013(3)
  • 8Tilak Shah.Drug-Eluting Stents in Malignant Biliary Obstruction: Where Do We Stand?[J].Digestive Diseases and Sciences.2013(3)
  • 9J.-M. Dumonceau,M. Delhaye,A. Tringali,J. Dominguez-Munoz,J.-W. Poley,M. Arvanitaki,G. Costamagna,F. Costea,J. Devière,P. Eisendrath,S. Lakhtakia,N. Reddy,P. Fockens,T. Ponchon,M. Bruno.Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline[J].Endoscopy.2012(08)
  • 10Dong Uk Kim,Chang‐Il Kwon,Dae Hwan Kang,Kwang Hyun Ko,Sung Pyo Hong.New antireflux self‐expandable metal stent for malignant lower biliary obstruction: In vitro and in vivo preliminary study[J].Digestive Endoscopy.2012(1)

共引文献26

同被引文献21

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部